Abstract A bacteriophage, designated UZ1 and showing lytic activity against a clinically important strain (BE1) of Enterobacter aerogenes was isolated from hospital sewage. The stability and lytic activity against this strain under simulated gastro-intestinal conditions was evaluated. After addition of bacteriophage UZ1 to a liquid feed at gastric pH 2, the phage was immediately inactivated and could not be recovered. However, by use of an antacid to neutralize stomach acidity, no significant changes in phage titer were observed after 2 h incubation at 37°C. After supplementing pancreatic juice and further incubation for 4 h, the phage titer remained stable. The persistence of UZ1 in a mixed microbial ecosystem that was representative for the large intestine was monitored using an in vitro simulation of the human intestinal microbial ecosystem. A pulse administration of bacteriophage UZ1 at a concentration of 10 5 plaque-forming units (PFU)/ml to reactor 3 (which simulates the ascending colon) showed that, in the absence of the host, bacteriophage UZ1 persisted for 13 days in the simulated colon, while the theoretical washout was calculated at 16 days. To assess its lytic activity in an intestinal microbial ecosystem, a green fluorescent protein (gfp)-labeled E. aerogenes BE1 strain was constructed and gfp-specific primers were designed in order to quantify the host strain using real-time PCR. It was observed that bacteriophage UZ1 was able to replicate and showed lytic activity against E. aerogenes BE1/gfp in an intestinal microbial ecosystem. Indeed, after 17 h a 2 log unit reduction of E. aerogenes BE1/gfp was measured as compared with the assay without bacteriophage UZ1, while the phage titer increased by 2 log units at an initial multiplicity of infection of 0.07 PFU/colonyforming unit. This is the first report of an in vitro model to study bacteriophage activity in the complex intestinal microbial community.
Introduction
Bacteriophages (phages), viruses with a bacterial host, are ubiquitous and highly diverse. They have been isolated from a wide variety of environments, including seawater (Borsheim 1993) , soil (Ashelford et al. 2003) , sewage (Ewert and Paynter 1980) , food products (Gautier et al. 1995; Josephsen and Neve 1998; Yoon et al. 2002) , and feces (Furuse et al. 1983 ). The property of phages to infect and lyse bacterial cells led to the therapeutic use of bacteriophages, the so-called phage therapy. The first report of phage therapy was by Felix d'Herelle in 1919 to treat a patient with dysentery (Summers 1999) . With the advent and success of antibiotics, phage therapy passed into oblivion. However, in the former Soviet Union the therapeutic use of bacteriophages was further developed, which resulted in a number of reports on the use of phage therapy in English literature Chanishvili et al. 2001; Sulakvelidze et al. 2001) . Experiments on laboratory animals and the use of phage therapy in veterinary medicine have also been reported (Smith and Huggins 1983; Berchieri et al. 1991; Soothill 1992; Ramesh et al. 1999; Biswas et al. 2002) .
In contrast, the human intestinal tract has been extensively studied and several in vitro systems have been developed (Molly et al. 1993; Hack and Selenka 1996; Macfarlane et al. 1998; Minekus et al. 1999; De Boever et al. 2001) . In vitro models offer defined experimental conditions and easy sampling. Also, the lack of ethical constraints when using in vitro model systems over human or animal subjects is an advantage. The simulation of the human intestinal microbial ecosys-tem (SHIME) is a five-stage reactor developed by Molly et al. (1993) and optimized by De Boever et al. (2001) .
As a model pathogen in this study, a clinical isolate of Enterobacter aerogenes, strain BE1, was used. Species of Enterobacter are opportunistic pathogens and rarely cause disease in the otherwise healthy individual. Most of these organisms are innately resistant to conventional antimicrobial agents and have the ability to rapidly develop resistance to newer agents. Among the Enterobacter genus, E. cloacae and E. aerogenes are the two species most frequently isolated from clinical samples; and these organisms belong to the normal digestive microbiota (Sanders and Sanders 1997) . Most nosocomial Enterobacter infections appear to arise indigenous from a previously colonized site in the patient (Flynn et al. 1987; Galili et al. 1992; Fryklund et al. 1994) . Colonization of the gastro-intestinal tract and other body sites with Enterobacter spp frequently occurs in the seriously ill patient, especially after prior antibiotic therapy (Gaston 1988; Falkiner 1992) . From a survey in Belgian hospitals from 1996 to 1998, the data collected suggested a nationwide dissemination of two epidemic multiresistant E. aerogenes strains (BE1, BE2) in Belgium. The BE1 type was indistinguishable from a previously described epidemic strain in France (De Gheldre et al. 2001) . Those facts indicate that the number of clinically important strains throughout Europe may be rather limited such that development of a controlling strategy for nosocomial E. aerogenes infections by host-specific bacteriophages may be feasible.
The objective of the present study was to develop an in vitro model to investigate bacteriophage stability and activity under gastro-intestinal conditions. The model consists of a bacteriophage (UZ1) and its host, a clinical isolate of E. aerogenes. Different aspects affecting bacteriophage stability during transit through the gastro-intestinal tract were evaluated, i.e. resistance to stomach acidity, bile, and pancreatin. Persistence in an intestinal microbial ecosystem was determined using the SHIME. Bacteriophage replication and host titer were monitored in a microbial community representative of that in the large intestine. This is the first report of an in vitro model study on bacteriophage activity in the complex microbial intestinal community.
Materials and methods

Bacteriophage UZ1
Bacteriophage UZ1 was isolated from hospital sewage (University Hospital, Ghent, Belgium), using an enrichment procedure. Sewage samples were centrifuged for 5 min at 10,000 g and the supernatant was filter-sterilized (0.22 µm). From the supernatant, aliquots of 8 ml were supplemented with 1 ml of 10× LB medium, 1 ml of a mid-log phase culture of E. aerogenes BE1, and incubated on a shaker for 4 h at 37°C. LB medium composition was (per liter): 10 g trypton (Applichem, Darmstadt, Germany), 5 g yeast extract (Applichem), and NaCl. After enrichment, samples were centrifuged for 5 min at 10,000 g and the supernatant was filter-sterilized (0.22 µm). To detect phages, the soft agar layer method described by Adams (1959) was applied, using serially dilutions of the supernatant in SM medium (50 mM Tris-HCl, pH 7.5, 100 mM NaCl, 10 mM MgSO 4 , 0.01% gelatin). In brief, 100 µl of serially diluted supernatant was mixed with 400 µl of a mid-log phase E. aerogenes BE1 culture and 2.5 ml of 0.5% agar (Federa, Brussels, Belgium). The mixture was poured over a Petri dish with LB agar (LB medium supplemented with 15 g agar/l) and incubated for 16 h at 37°C. Single plaques were picked and isolated again three times to ensure pure phage strains.
To prepare phage stock, a single plaque was diluted in 500 µl of SM medium and the soft agar layer method was used as described above, using 100 µl of the diluted plaque. Soft agar layers were removed from plates and diluted in 10 ml of SM medium. Phages were separated by centrifugation for 10 min at 10,000 g and filtersterilized (0.22 µm).
For the determination of phage titers, serial dilutions were plated using the soft agar layer technique, as described above.
Restriction analysis and transmission electron microscopy Bacteriophage DNA was extracted according to Hambly et al. (2001) . Restriction analysis and gel electrophoresis of bacteriophage DNA were executed as described by Sambrook and Russell (2001) . The restriction enzymes used were DraI, MspI, and EcoRI (Amersham Biosciences, Roosendaal, The Netherlands).
For transmission electron microscopy, bacteriophages were applied to copper-mesh grids and negatively stained with 2% uranyl acetate.
Host-range of bacteriophage UZ1
The host-range of bacteriophage UZ1 was determined by spotting phage UZ1 on bacterial lanes of E. aerogenes BE1 and five other strains (E. aerogenes BE2, E. aerogenes ATCC 13048, E. cloacae LM W011, Escherichia coli ESBL 111, E. coli ESBL 112). After overnight incubation at 37°C, bacterial lanes were screened for plaque formation. The clinical isolates were supplied from the collection of the Department of Clinical Chemistry, Microbiology and Immunology (Ghent University, Belgium).
Effect of pH, bile salts, and pancreatin on bacteriophage UZ1
The effect of pH was examined by diluting phage UZ1 to a final concentration of 6.2±0.3×10 5 plaque-forming units (PFU)/ml in SM medium set to different pH levels (pH 2, 4, 6, 7, 9) with 1 N NaOH or 1 N HCl. Samples were taken at the start of the experiment and after 1 h of incubation at 37°C. Phage titers were determined by the soft agar layer technique, as described above.
The effect of antacid, bile salts and pancreatin on bacteriophage UZ1 was studied as follows. In an Erlenmeyer flask (500 ml vol.), 1 ml of a phage stock at 8 log PFU/ml was added to 140 ml of a liquid reactor feed. The feed composition was identical to the SHIME reactor feed (per liter): 1 g arabinogalactan, 2 g pectin, 1 g xylan, 3 g potato starch, 0.4 g glucose, 3 g yeast extract, 1 g peptone, 4 g mucin, and 0.5 g cystein. The feed was autoclaved and the pH of the feed was set to 2 with 6 N HCl. For the treatment with antacid, 1.75 g NaHCO 3 was added prior to inoculation with phage. After incubation for 2 h at 37°C with shaking, 60 ml of pancreatic fluid was supplemented consisting of (per liter): 1.5 g pancreatin (Sigma), 6 g bile (oxgall; Difco), and 12.5 g NaHCO 3 . Erlenmeyers were incubated for another 4 h at 37°C with shaking. Samples (1 ml) were taken and pH was measured at the start, after 2 h, and at the end of the incubation. Samples were centrifuged for 5 min at 10,000g and the supernatant was used for the determination of phage titer as described above.
E. aerogenes BE1/gfp
Marking with gfp
The genes for the green fluorescent protein (gfp) fluorochrome and kanamycin resistance were inserted into the chromosome of E. aerogenes BE1. This was done by means of a biparental mating between E. coli S17-1 λpir (pUTgfp; Boon et al. 2001 ) and E. aerogenes BE1, with selection on LB plates with tetracyclin (20 mg/ l) and kanamycin (50 mg/l). The obtained marked cells were selected on their GFP fluorescence (excitation at 396/476 nm, emission at 508 nm) by a Dark Reader illuminator (Clare Chemical Research, Denver, Colo.). The infectivity of bacteriophage UZ1 was not affected after labeling E. aerogenes BE1 with the gfp gene.
Detection and quantification of the gfp gene
Total DNA extractions from bacterial culture of E. aerogenes BE1/ gfp and samples from the lytic activity assays were performed using the method adapted from Griffiths et al. (2000) and Kowalchuck et al. (1998) , as described by Boon et al. (2002) . The primers for realtime amplification of the Aequorea victoria gfp gene (GenBank accession number U73901.1) were constructed by the use of Primer Express ver. 2.0 (Applied Biosystems, Nieuwekerk a/d Ijssel, The Netherlands). The specificity of the designed primers was checked using the BLAST server of the National Center for Biotechnology Information, using the BLAST algorithm (Altschul et al. 1997) . The forward primer, GFP-F-272-293 (3′-GCCATGCCAGAAGGT-TATGTTC-5′; positions 272-293) and reverse primer GFP-R-356-332 (3′-CAAACTTGACTTCAGCTCTGGTCTT-5′; positions 332-356) amplified a PCR fragment of 85 bp.
Real-time quantitative PCR was performed using an ABI Prism SDS 7000 instrument (PE Applied Biosystems, Nieuwerkerk a/d Ijssel, The Netherlands). All reagents used to perform real-time PCR detection were purchased from Applied Biosystems. The amplification reactions were carried out with Sybr Green PCR master mix containing AmpliTaq Gold DNA polymerase, AmpErase uracil-Nglycosylase, Sybr GreenI, deoxynucleoside triphosphates with dUTP, and passive reference and optimized buffer components. The final concentrations of each oligonucleotide in the PCR mixture were 300 nM. The total volume of the PCR mixture was 25 µl, including 1 µl of DNA template, in MicroAmp Optical 96-well reaction plates with optical caps, and the PCR was carried out according to the instructions of the manufacturer. The PCR temperature program was as follows: 50°C for 2 min and 95°C for 10 min, followed by 40 cycles of 95°C for 15 s, and 60°C for 1 min. The concentrations of the primers and probes were optimized as described in the TaqMan universal PCR master mix protocol (Applied Biosystems).
The increase in emission intensity was measured during the amplification reaction by the ABI PRISM 7000 sequence detection system (SDS). Data acquisition and analysis were handled by ABI PRISM 7000 SDS software ver. 1.0 (Applied Biosystems). Briefly, a threshold is assigned to the log phase of product accumulation. The point at which the threshold crosses the amplification curve is defined as a cycle threshold value, termed C T . With increasing target quantity in the PCRs, the C T value decreases linearly and thus C T values can be used as quantitative measurements of the input target amount (Heid et al. 1996) .
The comparative C T method was used for quantitative analyses. Standard curves were constructed after real-time PCR amplification of DNA extracts of different E. aerogenes BE1/gfp cell numbers (n=4) ranging from 5.3×10 7 to 5.3×10 4 colony-forming units (CFU)/ well. The R 2 value was greater than 0.99 for the standard curves and a slope of −3.67 was generated. Based on the standard curve, the exact number of E. aerogenes BE1/gfp cells in the DNA extracts could be determined Simulator of the human intestinal microbial ecosystem The SHIME reactor setup was based on the adult SHIME (Molly et al. 1993; De Boever et al. 2001) . In brief, the SHIME was designed to maintain a microbial community that is representative of that in the human intestinal system. The SHIME consisted of five sequential reactors that represent the different parts of the intestinal tract: stomach and duodenum (reactor 1), jejunum and ileum (reactor 2), ascending colon (reactor 3), transverse colon (reactor 4), and descending colon (reactor 5). The first two reactors were of the fill-and-draw principle, while the last three were continuous stirred reactors with pH control. The overall residence time of the last three reactors, simulating the large intestine, was 76 h. The temperature of the system was kept at 37°C by a thermostat and the system was kept anaerobic by flushing with N 2 for 15 min every day. Inoculum preparation and reactor start-up were as described by De Boever et al. (2001) .
Persistence of bacteriophage UZ1 in the SHIME A single dose of phage UZ1 was administrated to reactor 3 to a final concentration of 1.0×10
5 PFU/ml. Samples were taken daily from reactors 3, 4, and 5, centrifuged for 5 min at 10,000 g, and filtersterilized. Phage titer was determined by the soft agar layer technique. The theoretical washout of inert particles was calculated using a first-order kinetics model: X t =X 0 ×e −kt , where X t is the phage concentration at time t, X 0 is the initial phage concentration, and k is determined by [(volume of feed/day)/volume of reactor 3].
Lytic activity assay
Experiments in triplicate were conducted in 100-ml penicillin bottles incubated at 37°C for 17 h. For lytic activity assays with SHIME suspension, the reactor content was removed from reactor 5 (descending colon) and 50-ml aliquots were transferred to penicillin bottles. E. aerogenes BE1/gfp and phage UZ1 were added to the penicillin bottles at the start of the experiment at final concentrations of 8.6±0.89×10 5 CFU/ml and 5.8±1.1×10 4 PFU/ml, respectively. Phage titers were determined by the soft agar layer technique and E. aerogenes BE1/gfp concentrations were determined by real-time PCR, using primers specific for the gfp gene sequence.
Results
Host-range of bacteriophage UZ1
Phage UZ1 was found to be infective only for E. aerogenes BE1 LMG 22092. No plaque formation was observed on the other strains tested: E. aerogenes BE2 LMG 22093, E. aerogenes ATCC 13048, E. cloacae LM W011 LMG 22094, E. coli ESBL 111 LMG 22095, and E. coli ESBL 112 LMG 22096.
Tentative classification of bacteriophage UZ1
After restriction of phage DNA with DraI, the size of the major bands were approximately 23,000 bp, 7,000 bp, and 4,000 bp (Fig. 1) . Phage DNA could not be restricted with EcoRI or MspI. Transmission electron microscopy revealed phage particles having an isometric head with a diameter of approximately 65 nm and a short non-contractile tail (Fig. 2) . These morphological properties and the estimated genome size of at least 34 kb correspond to the T7-like phages of the genus Podovirida (Order: Caudovirales).
After 1 h incubation at 37°C at different pH levels, there were no significant differences (P>0.05) between the initial phage titer of 6.2±0.3×10 5 PFU/ml and the phage concentrations at pH 9, 7, 6, and 4. However, at pH 2, the concentration of bacteriophage UZ1 dropped below the detection limit (1.0×10 1 PFU/ml) immediately after the addition of phage UZ1.
The effect of gastric acidity, bile salts, and pancreatin on bacteriophage UZ1 after addition of antacid (1.75 g NaHCO 3 ) is given in Table 1 . In the control reactors, phages were immediately inactivated and no phages could be detected throughout the incubation. However, in the reactors with antacid added prior to the administration of phage UZ1, there was no significant effect on the phage concentration during the 6 h of incubation.
Persistence of bacteriophage UZ1 in the SHIME The persistence of bacteriophage UZ1 in the simulated large intestine (reactors 3, 4, and 5; Fig. 3 ) was evaluated in the absence of the host, E. aerogenes BE1, and the theoretical washout was calculated. Before addition of the phage to the system, samples from the colon reactors were taken and screened for the presence of phages infective for E. aerogenes BE1. Since the soft agar layer technique detected no such phages, it can be assumed that the phages detected during the subsequent experiment were those added, i.e. phage UZ1. The detection limit of this experiment was 1.0×10 1 PFU/ml. Phage UZ1 could be detected for 7 days in reactor 3, while the calculated washout would have reached the detection limit after 9 days. For reactor 4, phage UZ1 was detectable until day 12, while the theoretical washout was 14 days. Phage UZ1 stayed detectable in reactor 5 for up to 13 days, while calculated washout reached the detection limit on day 16. Table 1 Effect of stomach acidity, bile salts, and pancreatin on the stability of phage UZ1. By the addition of pancreatic juice after 2 h of incubation at 37°C, the reactor volume increased from 140 ml to 200 ml and therefore the total number of plaque-forming units (PFU) per reactor is given. For each treatment, antacid (1.75 g NaHCO 3 ) was added prior to the addition of bacteriophage UZ1 (1 ml of 8.4±0.1 log PFU/ml) Lytic activity of bacteriophage UZ1 against E. aerogenes BE1/gfp was determined both in a monoculture with LB medium and in the presence of the microbiota from the SHIME. Results are presented in Fig. 4 . In the control assay with phage UZ1, but without E. aerogenes BE1/gfp, a limited inactivation of the phage was measured. Phage concentrations dropped from 5.8±0.1×10 4 PFU/ml to 2.0 ±0.1×10 4 PFU/ml for the assay with LB medium and 5.0 ±0.7×10 3 PFU/ml in the SHIME suspension. In the control assay with E. aerogenes BE1/gfp, but without phage UZ1, an increase was detected from 8.6±0.9×10
5 CFU/ml to 1.1 ±0.1×10 8 CFU/ml in the monoculture with LB medium and 6.9±1.4×10
6 CFU/ml in the assay harboring a SHIME microbial community. In the two assays with both phage UZ1 and strain BE1/gfp, bacteriophage UZ1 was able to replicate and the titer of strain BE1/gfp was below the initial level at the start of the experiment. In the assay with LB medium, the final concentration of E. aerogenes BE1/ gfp was 2.8±0.6×10 5 CFU/ml, while in the assay with the SHIME suspension, the final concentration dropped to 5.9 ±1.2×10 4 CFU/ml. Interestingly, although the phage titer in the assay with LB was higher than in the assay with the SHIME suspension, 1.4±0.1×10 8 PFU/ml and 7.4 ±0.8×10
6 PFU/ml, respectively, the lytic effect in the SHIME suspension was higher than in the LB medium.
Discussion
To our knowledge, this is the first report of a host-specific bacteriophage infecting E. aerogenes. Phage UZ1 was found to be infective only for the E. aerogenes strain BE1. It is possible that the isolation and propagation procedures had an influence on the very narrow host-range of phage UZ1. Phage UZ1 was isolated using an enrichment procedure, reisolated three times and further propagated on a single host, E. aerogenes BE1. Jensen et al. (1998) Fig. 3 Persistence of phage UZ1 (plaque-forming units, PFU) in the colon reactors (R3, R4, R5) of the simulation of the human intestinal microbial ecosystem (SHIME). The calculated theoretical washout (R3theor, R4theor, R5theor) is indicated by dotted lines. A single dose (1.0×10 5 PFU/ml) of phage UZ1 was added to reactor 3 at day 1. The detection limit was 1.0×10 1 PFU/ml. Bacteriophage UZ1 was detectable up to days 7, 12, and 13 in reactors 3, 4, and 5, respectively. Theoretical washout reached the detection limit after 9, 14, and 16 days in reactors 3, 4, and 5, respectively. d Days   Fig. 4 Lytic activity assays were executed in LB medium with a monoculture of Enterobacter aerogenes BE1/gfp or a SHIME suspension harboring a complex microbial ecosystem. E. aerogenes BE1/gfp (BE1) and phage UZ1 were added to final concentrations of 8.6±0.89×10
5 CFU/ml (indicated by the solid line) and 5.8 ±1.1×10 4 PFU/ml (indicated by the dotted line), respectively. The multiplicity of infection was 0.07 PFU/CFU observed that the frequency with which broad-host-range bacteriophages are isolated is increased by the use of multiple-host enrichment protocols and that single-host methods result in selection for narrow-host-range bacteriophages. The narrow-host-range of phage UZ1, limited to E. aerogenes BE1, is also reflected in the fact that there was no increase in phage titer in the lytic activity assay containing SHIME suspension without the host strain.
In contrast to antibiotics which have a broad-range bactericidal effect, the effect of host-specific bacteriophages on the commensal microbiota is very focused and chances of developing secondary infections are avoided (Chernomordik 1989; Sulakvelidze et al. 2001) . A study by De Gheldre et al. (2001) in Belgian hospitals revealed that E. aerogenes infections could be assigned to a limited number of strains, since 74% of all the isolated strains were identified as E. aerogenes strains BE1 or BE2 (De Gheldre et al. 2001) . Other studies also confirmed that nosocomial infections in many cases originate from a single (multiresistant) clone with a regional spread (Jalaluddin et al. 1998; Mammeri et al. 2001 ). These observations point to the potential of therapeutic use of phage UZ1 against E. aerogenes BE1 infections.
In the development of the model system in this work, propagation of the phage can be assumed to be solely due to the lytic activity on a single host strain, namely the gfplabeled E. aerogenes BE1. In this context, comparison with lytic activity in monoculture systems is relevant. The labeling with the gfp gene and the development of gfpspecific primers allowed real-time PCR quantification of E. aerogenes BE1/gfp in the complex gastro-intestinal microbial community. The marking of bacteria with the gfp gene is widely used in bacteriology and numerous gfplabeled strains are available. Therefore, the use of realtime PCR for the quantification of gfp-labeled strains, as presented in this study, can be expanded to other gfplabeled strains and different complex ecosystems. Figure 4 illustrates that there is more proliferation of phage UZ1 in the lytic activity assay with LB medium than in the SHIME suspension. The monoculture in LB medium offers high nutrient levels for optimal growth of the bacterial strain, resulting in more effective phage replication, as they employ the host's cellular machinery (Middelboe 2000) . In the treatment with SHIME suspension, a lower energy level of the host can be expected, due to medium composition and competition with other species. Also, the presence of non-host material of physical or biological origin interfering with the attachment of the phage to its host can be the cause of the lower phage replication. The final lytic effect is the result of two related processes, i.e. bacterial growth rate and phage replication. Although there was more phage replication in the E. aerogenes BE1/gfp culture in LB medium, the observed lytic effect was more pronounced in the reactor with the SHIME suspension. These results were obtained within the limited time frame of the lytic activity assays and at a multiplicity of infection (MOI) of only 0.07 PFU/ CFU. For therapeutic applications, a higher MOI is favorable and could be achieved as phage stock solutions of the order of 10 9 PFU/ml can be produced. The acidity of the stomach forms a major barrier when applying phages by oral administration. Phage UZ1 was stable in the range pH 4-9. At pH 2, there was immediate and irreversible inactivation of the phage. Slopek et al. (1983) describe the use of antacid when administering phages orally. Indeed, the use of an antacid like NaHCO 3 proved to be very effective in neutralizing the stomach acidity and no significant effects of bile salts and pancreatin were observed. Therefore, the transfer of phages through the stomach should be designed in a way which protects the phages against the stomach acidity. Once the phages arrive in the small and large intestine, it can be expected that they adequately withstand the ambient chemical and enzymatic conditions.
Although phage UZ1 persisted not as long in reactor 3 as calculated for the washout of inert particles, it stayed detectable in the system for 13 days, while the calculated washout reached the detection limit after 16 days. This implies that phage UZ1 is relatively resistant to intestinal conditions but is washed out of this environment in the absence of the host. There was also some inactivation observed in the lytic activity assays, where phage UZ1 was more inactivated in the presence of the SHIME suspension, compared with the reactor with only LB medium. Interaction with non-host material and adsorption onto the matrix are plausible causes for these observations. The SHIME, like other similar in vitro simulators, is a valuable tool for studying microbiological processes in the gastro-intestinal system. Until now, interactions with the human host (like cellular transport mechanisms or the immune system) were not incorporated in these in vitro models. With respect to bacteriophages, it is not clear whether bacteriophages are able to pass the human luminal barrier. A few studies on laboratory animals suggest that phages enter the bloodstream after oral administration within 2-4 h and that they could be found in the internal organs like liver, spleen, kidney, etc. (Bogovazova et al. 1991 (Bogovazova et al. , 1992 . The development of neutralizing antibodies after the administration of phages to humans is documented (Kucharewicz-Krukowska and Slopek 1987) . These antibodies could reduce the effectiveness of phage replication. Because the kinetics of bacteriophage replication are much faster than the development of phage-neutralizing antibodies, this probably will have a limited effect, at least in the short term (Sulakvelidze et al. 2001 ).
In conclusion, we developed a model system to study bacteriophage persistence and lytic activity under simulated intestinal conditions. Bacteriophage UZ1 persisted for a prolonged period in reactors simulating the different parts of the large intestine. Furthermore, lytic activity assays showed proliferation of the bacteriophage; and the concentration of the gfp-labeled host strain could be quantified. The SHIME model was found to be a valuable tool for research in the field of phage ecology and putative phage therapy.
